Humphrey Zeiss FDT
AMERICA North (USA-Canada-Mexico)
Humphrey FDT – for efficient visual field loss detection Clinically validated Multiple studies1-15 have shown that
the Humphrey FDT detects visual field loss due to a variety of ocular diseases, including glaucoma.
Thus FDT is ideal for clinics desiring to identify patients in need of ophthalmological referral.
FDT is clinically validated in more than 170 peer-reviewed publications. Proven performance on virtually all patients
Studies have found that virtually all patients can perform this fast and simple test with reliable results: • Beijing Eye Study: 98% patient success. 14
Tajimi Population Screening Study: 98.7% patient success.15 Easy to operate and interpret
The FDT is optimized for use in non-ophthalmological settings and may be operated by
healthcare workers having little or no specialty training in ophthalmology.
Simplified three touch operation.
Patients may be tested using their own glasses.
Short test: ~ 40 seconds per eye.
Small footprint.
Simplified interpretation of results. Both the Matrix and FDT also provide
Large, age-related normative database.
Compact design that fits anywhere in your practice.
Easy and intuitive operation for users of any level of experience.
No requirement for trial lenses or eye patches.
Dependable performance in ambient light.